HPN424 Shows Promising Safety, Immune Activation in Metastatic CRPC

[Moespy]

Early (Trial Phase 1) but good results (link below) for this PSMA drug for mCRPC patients. Trial with patients already through Xtandi and/or Zytiga. Trial is still recruiting for those that may be interested and qualify. Article has trial link.

prostatecancernewstoday.com...

[NPfisherman]

Thanks for posting, Moespy....I follow this one, TAS3681, TRC253, MM310, RRx-001, and waiting for the Match Trial to start, and Checkmate 650 to be completed...I feel like Paul Revere..."The drugs are coming, The drugs are coming..."...but dang it, we have to wait for years....safety first, and efficacy next...but RRX-001 is phase 3, and Checkmate is going strong...gotta hang on...

All the best,

Fish

[Jbooml]

Do like the molecule trifectively binding Tcells to tumor PSM antigens.....definitely bookmarking this

[tallguy2]

Thank you for posting!